Posted on Aug 6, 2023
RSV prevention shot for babies gets OK from CDC
185
2
1
2
2
0
https://www.npr.org/sections/health-shots/2023/08/05/ [login to see] /rsv-prevention-cdc-nirsevimab
This fall, for the first time, many babies in the U.S. will be eligible to get a shot to fend off RSV, a respiratory virus that can cause serious lung disease in infants and young children.
On Thursday, the Centers for Disease Control and Prevention recommended that all infants under 8 months old receive an injection of nirsevimab, a newly approved monoclonal antibody, as they enter their first RSV season (usually fall through spring). A subset of children up to 19 months at heightened risk of serious RSV disease – including those with chronic lung disease, and American Indian and Alaska Native children – can get a shot in their second RSV season.
"RSV is the leading cause of hospitalizations for infants and older babies at higher risk, and today we have taken an important step to make this life-saving product available," said Dr. Mandy Cohen, director of the CDC, in a statement.
This fall, for the first time, many babies in the U.S. will be eligible to get a shot to fend off RSV, a respiratory virus that can cause serious lung disease in infants and young children.
On Thursday, the Centers for Disease Control and Prevention recommended that all infants under 8 months old receive an injection of nirsevimab, a newly approved monoclonal antibody, as they enter their first RSV season (usually fall through spring). A subset of children up to 19 months at heightened risk of serious RSV disease – including those with chronic lung disease, and American Indian and Alaska Native children – can get a shot in their second RSV season.
"RSV is the leading cause of hospitalizations for infants and older babies at higher risk, and today we have taken an important step to make this life-saving product available," said Dr. Mandy Cohen, director of the CDC, in a statement.
RSV prevention shot for babies gets OK from CDC
Posted from npr.orgPosted in these groups: 
Children
Medical
Health
PharmaceuticalsCenters for Disease Control and Prevention
Children Medical Health PharmaceuticalsCenters for Disease Control and Prevention
Posted 10 mo ago
Responses: 1
0
0
0
PO1 William "Chip" Nagel
..."Competitors, too
Beyfortus's launch will broaden the protection available for babies. Prior to this approval the only existing preventive drug for RSV was a monoclonal antibody shot called palivizumab, which requires monthly administration and is reserved for babies at high medical risk.
This antibody shot is one of several new drugs and vaccines in development to protect babies and the elderly from RSV. By late August, the FDA is expected to issue a decision on an RSV vaccine to protect newborns that is given to pregnant mothers."
..."Competitors, too
Beyfortus's launch will broaden the protection available for babies. Prior to this approval the only existing preventive drug for RSV was a monoclonal antibody shot called palivizumab, which requires monthly administration and is reserved for babies at high medical risk.
This antibody shot is one of several new drugs and vaccines in development to protect babies and the elderly from RSV. By late August, the FDA is expected to issue a decision on an RSV vaccine to protect newborns that is given to pregnant mothers."
(0)
(0)
Read This Next
Continue with Facebook 
Continue with Google